News

Search for Articles
Dec 9, 2021
Aeromics and Simcere Announce the First-In-Human Dosing of Chinese Healthy Volunteers in Simcere’s Phase I Study of The SIM0307 (AER-271), A New Drug for Brain Edema

NEW HAVEN, Conn. and NANJING, China, Dec. 9, 2021 /PRNewswire/ -- Simcere Pharmaceutical Group and Aeromics,...

Read More
Nov 15, 2021
Renovacor Announces Third Quarter 2021 Financial Results and Provides Corporate Update

PHILADELPHIA--(BUSINESS WIRE)-- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies...

Read More
Oct 4, 2021
Renovacor Announces the Appointment of Kumar Dhanasekharan, Ph.D., as Senior Vice President of Technical Operations

PHILADELPHIA--(BUSINESS WIRE)--Renovacor, Inc. (NYSE: RCOR), a biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for...

Read More
Sep 22, 2021
Renovacor Announces the Appointment of Jordan Shin, M.D., Ph.D., as Senior Vice President of Clinical Development and Translational Science

Dr. Shin to help advance REN-001 into the clinic by leveraging nearly two decades of...

Read More
Sep 2, 2021
Renovacor, Inc. Closes Its Business Combination with Chardan Healthcare Acquisition 2 Corp. and Will Begin Trading on the New York Stock Exchange

PHILADELPHIA--(BUSINESS WIRE)--Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for...

Read More
Sep 1, 2021
Chardan Healthcare Acquisition 2 Corp. Announces Stockholder Approval Of Business Combination With Renovacor, Inc.

NEW YORK, Sept. 1, 2021 /PRNewswire/ -- Chardan Healthcare Acquisition 2 Corp. (NYSE: CHAQ) ("CHAQ"),...

Read More
9101112131415